Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $136.8 million.

  • Bio-Techne's Operating Expenses fell 658.92% to $136.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $675.8 million, marking a year-over-year increase of 1559.42%. This contributed to the annual value of $688.0 million for FY2025, which is 2219.7% up from last year.
  • Bio-Techne's Operating Expenses amounted to $136.8 million in Q4 2025, which was down 658.92% from $140.5 million recorded in Q3 2025.
  • Bio-Techne's 5-year Operating Expenses high stood at $222.7 million for Q2 2025, and its period low was $99.6 million during Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $126.3 million (2022), whereas its average is $133.3 million.
  • Per our database at Business Quant, Bio-Techne's Operating Expenses skyrocketed by 4507.59% in 2021 and then crashed by 801.82% in 2023.
  • Over the past 5 years, Bio-Techne's Operating Expenses (Quarter) stood at $121.3 million in 2021, then decreased by 4.84% to $115.5 million in 2022, then grew by 20.02% to $138.6 million in 2023, then rose by 5.69% to $146.5 million in 2024, then decreased by 6.59% to $136.8 million in 2025.
  • Its last three reported values are $136.8 million in Q4 2025, $140.5 million for Q3 2025, and $222.7 million during Q2 2025.